Abstract:RELMα is a small, secreted protein expressed by type 2 cytokine-activated “M2” macrophages in helminth infection and allergy. At steady state and in response to type 2 cytokines, RELMα is highly expressed by peritoneal macrophages, however, its function in the serosal cavity is unclear. In this study, we generated RELMα TdTomato (Td) reporter/knockout (Rα Td ) mice and investigated RELMα function in IL-4 complex (IL-4c)-induced peritoneal inflammation. We first validated the RELMα Td/Td transgenic mice and showed that IL-4c injection led to the significant expansion of large peritoneal macrophages that expressed Td but not RELMα protein, while RELMα +/+ mice expressed RELMα and not Td. Functionally, RELMα Td/Td mice had increased IL-4 induced peritoneal macrophage responses and splenomegaly compared to RELMα +/+ mice. Gene expression analysis indicated that RELMα Td/Td peritoneal macrophages were more proliferative and activated than RELMα +/+ macrophages, with increased genes associated with T cell responses, growth factor and cytokine signaling, but decreased genes associated with differentiation and maintenance of myeloid cells. We tested the hypothesis that Rα Td/Td macrophages drive aberrant T cell activation using peritoneal macrophage and T cell co-culture. There were no differences in CD4 + T cell effector responses when co-cultured with RELMα +/+ or RELMα Td/Td macrophages, however, RELMα Td/Td macrophages were impaired in their ability to sustain proliferation of FoxP3 + regulatory T cells (Treg). Supportive of the in vitro results, immunofluorescent staining of the spleens revealed significantly decreased FoxP3 + cells in the RELMα Td/Td spleens compared to RELMα +/+ spleens. Taken together, these studies identify a new RELMα regulatory pathway whereby RELMα-expressing macrophages directly sustain Treg proliferation to limit type 2 inflammatory responses.

The Transcription Factor RelB Restrains Group 2 Innate Lymphoid Cells and Type 2 Immune Pathology in Vivo.

Role of the NF-κB Family Member RelB in Regulation of Foxp3+ Regulatory T Cells in Vivo.

E3 Ubiquitin Ligase Cbl-b Inhibits Type 2 Innate Lymphoid Cell Development by Targeting ST2 for Ubiquitination

Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation

The transcriptional repressor Bcl6 controls the stability of regulatory T cells by intrinsic and extrinsic pathways.

The Origin and Role of Innate Lymphoid Cells in the Lung

The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.

Differential Role of Id2 in the Group 3 Innate Lymphoid Cells for the Development of Different Gut Associated Lymphoid Tissues

RAG suppresses group 2 innate lymphoid cells

Macrophage-Regulatory T Cell Interactions Promote Type 2 Immune Homeostasis Through Resistin-Like Molecule α

Promyelocytic leukemia zinc finger controls type 2 immune responses in the lungs by regulating lineage commitment and the function of innate and adaptive immune cells

Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity

Retinoid X Receptor Gamma Dictates the Activation Threshold of Group 2 Innate Lymphoid Cells and Limits Type 2 Inflammation in the Small Intestine.

ILC2s Induce Adaptive Th2-type Immunity in Different Stages of Tuberculosis Through the Notch-GATA3 Pathway.

Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness

Innate Lymphoid Cells Support Regulatory T Cells in the Intestine Through Interleukin-2.

Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity

ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses

Cross-talk between ILC2 and Gata3 high T regs locally constrains adaptive type 2 immunity

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells